GE HealthCare unveils Pristina Via to streamline technologist workflow and improve patient-centered breast care

GEHC 11.26.2024

Full Press ReleaseSEC FilingsOur GEHC Tweets

About Gravity Analytica

Recent News

  • 01.15.2025 - University of California San Francisco and GE HealthCare Launch a Joint Research Program to Drive Innovations in Imaging, Brain Health and Precision Oncology
  • 01.14.2025 - Sutter Health and GE HealthCare enter strategic partnership to benefit patients, physicians and clinicians with advanced, AI-powered imaging
  • 12.12.2024 - GE HealthCare to announce fourth quarter and full year 2024 results on February 13, 2025

Recent Filings

  • 12.12.2024 - 8-K Current report
  • Amid technologist shortage, new mammography innovation was designed through intensive collaboration with technologists will help to streamline workflow and humanize care

CHICAGO--(BUSINESS WIRE)--Nov. 26, 2024--TodayGE HealthCareannounced the new Pristina ViaTM* mammography system designed to enhance the screening experience for both technologists and patients. Debuting at the Radiological Society of North America’s 2024 Annual Meeting, this innovation provides mammography technologists with a suite of sophisticated tools that balance the demands of diagnostic accuracy and fast-paced workflows to facilitate more patient-centered breast care.

Recent data from theAmerican Society of Radiologic Technologists(ASRT) highlights a dramatic increase in technologist vacancy rates—from 6% three years ago to 18% in 2024—while the number of women seeking mammograms has remained steady.1Amid this global shortage of technologists,1the demand for more efficient and intelligent workflows is at an all-time high.

As the company continues to evolve the patient-centric Senographe Pristina platform,Pristina Viabrings advanced new features to help minimize repetitive tasks and streamline workflows so that mammography technologists can maintain their focus on providing quality and personalized care during the screening experience.

“At GE HealthCare, we are dedicated to addressing our customers’ needs by delivering solutions that enhance the experience for both patients and healthcare professionals,” saidJyoti Gupta, PhD – President & CEO for Women’s Health and X-ray atGE HealthCare. “Pristina Via represents a significant evolution in our patient focused Senographe Pristina platform which was designed by women for women. With the new in-room workflow,Pristina Viaminimizes laborious tasks and provides technologists with the gift of time to prioritize what matters most: compassionate, patient-centered care.”

Setting a New Standard in Breast Imaging

The Pristina Via mammography system takes in-room workflow and patient comfort to the next level through:

  • Zero-click acquisitionfunctionality for faster, seamless workflows.
  • No wait time between exposures, allowing technologists to operate at their own speed. Pristina Via DBT image-to-image cycle time is up to twice as fast as other mammography systems on the market.2
  • Vendor-neutral prior image comparison, reducing time spent analyzing previous exams and enabling final assessments more efficiently.
  • Lowest radiation dose usedfor all breast thicknesses amongst major mammography systems.3

The Pristina Via utilizes these advanced features to streamline technologists’ workflow and enable exceptional speed. Additionally,Pristina Viaalso features a future-focused, scalable platform with full backward compatibility to provide imaging centers access to the latest capabilities while also providing flexibility to support the evolving needs of their sites.Pristina Viais built on the Pristina platform which provides exceptional reliability. The Pristina platform is supported byGE HealthCareservice contracts and warranty, under which the Pristina systems demonstrate a 99% uptime.4

Designed with Technologists in Mind

GE HealthCaredeveloped the Pristina Via to build on its commitment of developing innovation to solve the challenges that patients and users face. The company performed almost 250 interviews and observations5with mammography technologists, which revealed that technologists’ greatest challenge is keeping up with the rapid pace of modern medicine without sacrificing accuracy or patient-centered care.

“Simplifying, automating, and streamlining the mammography exam to improve in-room workflows is critical to driving patient compliance and access to screening,” said Dr.John Simon, CEO of SimonMed, one of the largest nationwide outpatient imaging providers serving hundreds of thousands of women with breast cancer screening and diagnostic services annually. “As a leading mammography provider in the country, we are actively investing in new technologies, workflows and AI innovation that improve clinical and operational outcomes. The enhancements offered byPristina Viaare part of our mission of making advanced technology accessible.”

“During our intensive collaboration with our end users in the design phase, we heard time and again that the technologist’s workday can feel like a race against the clock,” saidPooja Pathak, Vice President and General Manager for Global Mammography atGE HealthCare. “Pristina Via is our answer to this challenge. The system’s advanced features were engineered to automate processes and allow our users to give patients the attentive, quality care they deserve. I am thrilled that SimonMed our longtime customer, will be implementing this new technology as part of their mammography services.”

For more information on GE HealthCare’s women’s health technology at RSNA, including thecompany’s new collaboration with RadNet’s DeepHealth, please visit Booth 7330 at RSNA,the RSNA 2024 press kitor theRSNA 2024 events page.

AboutGE HealthCare Technologies Inc.GE HealthCareis a leading global medical technology, pharmaceutical diagnostics, and digital solutions innovator, dedicated to providing integrated solutions, services, and data analytics to make hospitals more efficient, clinicians more effective, therapies more precise, and patients healthier and happier. Serving patients and providers for more than 125 years,GE HealthCareis advancing personalized, connected, and compassionate care, while simplifying the patient’s journey across the care pathway. Together our Imaging, Advanced Visualization Solutions, Patient Care Solutions, andPharmaceutical Diagnosticsbusinesses help improve patient care from diagnosis, to therapy, to monitoring. We are a$19.6 billionbusiness with approximately 51,000 colleagues working to create a world where healthcare has no limits.

Follow us onLinkedIn,X,Facebook,Instagram, andInsightsfor the latest news, or visit our websitehttps://www.gehealthcare.comfor more information.

__________________________________

*Pristina Viais commercial name of Senographe Pristina.

1

https://www.rsna.org/news/2024/october/radiologic-technologist-shortage

2

Image to Image cycle time is the minimum waiting time by the System between two consecutive images. Measured with ACR phantoms forPristina Viacompared to claimed performance of competitor (Dimension 3D_ in Product Data Sheet from Jul-2024)

3

Phantom measurements as ofJuly 2024. Senographe Pristina with default value STD mode. Dose comparison based on NHS Breast Screening Programme equipment reports.https://medphys.royalsurrey.nhs.uk/nccpm/?s=technicalreports.

4

1) Analysis of the 42543 Service requests on Pristina platform systems under Contract or Warranty fromJanuary 2022toSeptember 2024; 2) Since there is no “typical” hospital and many variables exist, i.e., hospital size, working days, working hours, there can be no guarantee that each Pristina system will achieve the same results.

5

Opportunity Discovery & Product Strategy Proposal forGE Healthcare, Strategyn, May-September 2024. GE HealthCare Data on File.

View source version onbusinesswire.com:https://www.businesswire.com/news/home/20241126789290/en/

GE HealthCare Media Contact:

Linh DinhCommunications Director408.275.5682Linh.Dinh@geheatlhcare.com

Source:GE HealthCare Technologies Inc.

Please be aware that the following content has been generated by an AI system and may contain errors, inconsistencies, or outdated information. It is provided as-is without any warranties or guarantees of accuracy. We strongly recommend using this content as a starting point for further research and consultation with relevant experts or authorities. We disclaim any liability for damages or losses resulting from the use or reliance on this content.Please note that this is a beta version of the Gravity Analytica LLC’s AI Service which isstill undergoing final testing before its official release. Theplatform, its software and all content found on it are provided on an“as is” and “as available” basis. Gravity Analytica LLC does not give any warranties,whether express or implied, as to the suitability or usability of thisservice, webpage, or its software or any of its content.Should you encounter any bugs, glitches, lack of functionality orother problems on the website, please let us know immediately so wecan rectify these accordingly. Your help in this regard is greatlyappreciated! You can write to us at this addressteam@gravityanalytica.com